News >> Health >> Pharmaceutical Executive

Tuning Into CTV - Real Time Data For Marketers


How Clinical Trials Can Thrive in the Digital Era


Lasso's Endemic Marketplace Unlocks Elusive HCPs for BioPharm Communications


ProofPilot Announces Strategic Partnership with Savvy Cooperative


Biopharma Leaders Prepare to Navigate Medicare’s New Negotiating Power


Effects of Ransomware on the Pharmaceutical Industry


Top cybersecurity threats, challenges pharma companies need to address


How CROs Are Leveraging Innovation to Accelerate Clinical Trials


3 Reasons to Consider Tech Consolidation in your Life Sciences Learning Environment


Automating Study Setup with a Digital Data Flow


Clarivate Names Highly Cited Researcher 2022 Designations


Fingerpaint Group Introduces Fingerpaint Market Access


Optimizing Your Promotional Investment Mix: Harness the Power of AI


Brand Institute Partners on Brand Name Development for FDA-Approved Treatment for Pulmonary Arterial Hypertension


A Culture of Quality: The Catalyst to Accelerate Innovation


Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics


A Mission of the Heart


The New Reality for Industry Dealmaking May be Setting In


Is ESG a ‘Protection Racket’ or Long-Term Value Contributor?


Digital Biomarkers Could Reshape CNS Diagnosis, Treatment


Recaps, Live & In Person


Pharmaceutical Executive, November 2022 Issue (PDF)


In life sciences, the metaverse opportunity knocks


Indegene to Help Scale Cup AstraZeneca's Global Omnichannel Operations


How EU 536/2014 Will Revolutionize Global Clinical Trials


How to Have a Successful Promotional Content Journey from Pre-commercial to Post-launch


FDA Embroiled in Reproductive Rights Debate


Origins Insights Announces Transition to Patient Specialist Agency


    

2022-11-27 22:25:05